Reply to Lutgring et al

Clin Infect Dis. 2022 Oct 29;75(9):1678-1679. doi: 10.1093/cid/ciac376.

Charles Darkoh^{1

2}, Herbert L DuPont^{1

2

3}, Cesar A Arias^{1

2

4}, Micah Oyaro⁵, Eric L Brown¹, Blake M Hanson¹

¹ University of Texas Health Science Center, School of Public Health, Department of Epidemiology, Human Genetics, and Environmental Sciences, Center for Infectious Diseases, Houston, Texas, USA.
² University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Microbiology and Infectious Diseases Program, Houston, Texas, USA.
³ Kelsey Research Foundation, Houston, Texas, USA.
⁴ Division of Infectious Diseases and Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern School of Medicine at Houston, Houston, Texas, USA.
⁵ University of Nairobi, School of Medicine, College of Health Sciences, Nairobi, Kenya.

No abstract available

Publication types